Home Cart Sign in  
Chemical Structure| 524-36-7 Chemical Structure| 524-36-7

Structure of Pyridoxylamine 2HCl
CAS No.: 524-36-7

Chemical Structure| 524-36-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pyridoxylamine 2HCl is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor.

Synonyms: Pyridoxylamine; Pyridoxylamine(dihydrochloride)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pyridoxylamine 2HCl

CAS No. :524-36-7
Formula : C8H14Cl2N2O2
M.W : 241.12
SMILES Code : OC1=C(CN)C(CO)=CN=C1C.[H]Cl.[H]Cl
Synonyms :
Pyridoxylamine; Pyridoxylamine(dihydrochloride)
MDL No. :MFCD00012808
InChI Key :HNWCOANXZNKMLR-UHFFFAOYSA-N
Pubchem ID :10664

Safety of Pyridoxylamine 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat small intestine epithelium cells IEC-6 1 mM 1 hour Pretreatment with PM significantly increased clonogenic survival of IEC-6 cells at all examined doses (up to 8 Gy), with maximum protection achieved at 1 mM PM. PM showed better protection at 2 Gy compared to Amifostine. Free Radic Biol Med. 2009 Sep 15;47(6):779-85
LA7 rat mammary tumor cells 100 µM 24, 48, 72 hours To evaluate the effect of pyridoxamine on the antitumor efficacy of doxorubicin. Results showed that pyridoxamine did not affect the effects of doxorubicin on LA7 cell viability, proliferation, cytotoxicity, and apoptosis. Cells. 2024 Jan 9;13(2):120

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Zebrafish PNPO-deficient zebrafish model Embryo water 0.1 mM Continuous exposure starting from 1 hpf Pyridoxamine showed rescue effects even at a lower concentration than PLP, presenting a possible new therapeutic treatment for PNPO-deficiency NEE. Front Pharmacol. 2019 Sep 20;10:1086
Sprague Dawley rats Doxorubicin-induced cardiomyopathy model Oral 1 g/L 8 weeks To assess the protective effect of pyridoxamine on doxorubicin-induced cardiomyopathy. Results showed that pyridoxamine significantly attenuated the doxorubicin-induced reduction in cardiac function and increase in left ventricular end-systolic volume. Cells. 2024 Jan 9;13(2):120
Rats Western diet-induced prediabetic rat model Drinking water 1 g/L Continued for 18 weeks Pyridoxamine improved cardiac fibrosis and oxidative stress in Western diet-induced prediabetic rats. Int J Mol Sci. 2024 Aug 4;25(15):8508
Female Sprague Dawley rats Doxorubicin-induced cardiomyopathy model Oral 1 g/L in drinking water Continuously for eight weeks Pyridoxamine significantly attenuated DOX-induced left ventricular dilated cardiomyopathy, limited TGF-β1-related LV fibrotic remodeling and macrophage-driven myocardial inflammation, protected against DOX-induced ferroptosis, restored redox balance, improved cytosolic and mitochondrial iron regulation, and reduced mitochondrial damage. Antioxidants (Basel). 2024 Jan 17;13(1):112
C57/BL/6J mice Whole-body radiation-induced apoptosis model in small intestine epithelium Drinking water 150 mg/kg/day 24 hours PM pretreatment significantly inhibited radiation-induced apoptosis in mouse small intestine epithelium at both 4 Gy and 8 Gy doses. PM was more effective than Amifostine at 8 Gy. Free Radic Biol Med. 2009 Sep 15;47(6):779-85
Male C57BL/6 mice Aged mouse model Oral (via drinking water) 2 g/L 6-8 months To investigate the effects of pyridoxamine on blood pressure, large artery stiffness, cerebral artery function, and cognitive function in old mice. Results showed that pyridoxamine treatment reduced large artery stiffness, maintained cerebral artery endothelium-dependent dilation, and partially preserved cognitive function in old mice. J Cereb Blood Flow Metab. 2023 Feb;43(2):281-295
Sprague-Dawley rats Diabetes model Drinking water 2 mg/mL Continued for 12 weeks PM treatment significantly inhibited accumulation of HOCl-derived modifications in collagen IV in diabetic animals compared to untreated diabetic animals. Free Radic Biol Med. 2015 Dec;89:83-90
Zucker Diabetic Sprague Dawley (ZDSD) rats Type 2 diabetes mellitus (T2DM) rat model Oral (dissolved in drinking water) 200 mg/kg/day Daily administration for 8 weeks To evaluate the inhibitory effect of pyridoxamine on intervertebral disc (IVD) degeneration in type 2 diabetic rats. Results showed that PM treatment reduced glycated serum protein (GSP) levels, attenuated IVD dehydration, decreased AGE accumulation in the IVD and endplate fibrocartilage, and increased aggrecan levels within the IVD. Int J Mol Sci. 2020 Dec 19;21(24):9709

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.15mL

0.83mL

0.41mL

20.74mL

4.15mL

2.07mL

41.47mL

8.29mL

4.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories